Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment.
Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment. Arch Ophthalmol. 2010 Aug; 128(8):1080-1.